2007
♦ BioMedix exceeds the 40,000 test mark in patient tests using PADnet™ in April.
2006
♦ BioMedix joins 45 medical societies and associations in becoming a Corporate Member of the PAD Coalition, a non-profit group dedicated to education and advocacy in promoting the early detection and treatment of Peripheral Arterial Disease. The PAD Coalition estimates that over 8 million Americans currently have PAD, and that without detection, 30% of these people will die of PAD related heart attack or stroke within five years. Others will lose limbs due to PAD.
♦ BioMedix exceeds the 20,000 test mark in patient tests using PADnet™. The 20,000th test was performed in a Family Practice medical clinic in North Carolina.
2005
♦ American Podiatric Medical Association (APMA) awards the BioMedix PADnet solution its Seal of Approval. The Seal is designed to inform podiatric physicians and consumers about quality, safety and effectiveness of medical products.
♦ BioMedix receives 2005 Product Leadership Award for PADnet from Frost and Sullivan, a leading independent market research firm.
♦ BioMedix introduces CustomLab® SQL Edition software product (now TRAKnet™ Lab), based on a client server architecture which supports Microsoft SQL-server back end databases. Benefits include data encryption and password protection (HIPAA requirements), stability, and industry leading vascular program efficiencies in workflow, clinical documentation, billing and reporting.
2004
♦ BioMedix releases PADnet, the first reimbursable peripheral arterial disease diagnostic device that can be used by medical staff in primary and podiatric care settings. PADnet studies can be interpreted by vascular specialists via secure Web links.
♦ BioMedix receives FDA marketing clearance for PADnet as a 501K equivalent predicate device. This breakthrough technology eliminates the need for Doppler, a technician dependent means of obtaining ankle-brachial indices. Instead, PADnet uses oscillometric means — measuring oscillations caused by the arterial pressure pulse — to determine segmental blood pressures. Combining ABI with Pulse Volume Recording and Internet tools, PADnet allows primary care physicians and podiatrists to communicate remotely with vascular specialists for interpretation of test results and prescription for follow-up care.
♦ BioMedix releases version 4 of its proven Vascular Lab Management Software, CustomLab. This software supports data transfer from the entire line of GE LOGIQ series ultrasound imagers, including the LOGIQ 7, LOGIQ 700, LOGIQ 9; as well as the LOGIQ Book. With the push of a button, CustomLab can acquire study data from BioMedix test devices and duplex ultrasound imagers. This direct download saves data entry time, and reduces errors in transcription.
♦ The Vascular Diagnostic Lab (VDL) product runs on the proven Windows XP Professional software platform — offering greater stability, networking support (for both wired and wireless networked computers), and patient record security.
2003
♦ BioMedix merged with A&A Medical, developer of CustomLab software for vascular laboratory management and OTIS™ (Outcomes Tracking System) software (now TRAKnet™ Outcomes) for vascular surgery outcomes management. These software programs made significant advances in ease-of-use and interoperability with diagnostic imaging and physiologic test equipment. CustomLab and OTIS became platforms for the development of PADnet.
♦ BioMedix transitions to the new ISO 9001:2000 Manufacturing Quality Standards and was recommended for certification to the new ISO Quality criteria by BSI, Management Systems in its certification audit.
2002
♦ Chris Evert, former tennis star, hosts BioMedix video to raise awareness of the under-diagnosed and under-treated problem of Peripheral Vascular Disease.
2001
♦ Sports commentator Pat Summerall hosts two-minute television segment on Fox Cable News profiling BioMedix. BioMedix achieves ISO Certification and CE Marking for its Portable Vascular Lab (PVL) product.
1998
♦ BioMedix introduced the Vascular Diagnostic Lab (VDL), a bilateral simultaneous testing device for lower extremity arterial physiological testing. The VDL was the first physiologic test device to run on the MS Windows operating system platform.
1997
♦ BioMedix was established in Minnesota’ Medical Alley to create innovative user-friendly solutions to detect peripheral vascular disease. The initial offerings were easy-to-use hardware and software for vascular laboratories. The BioMedix Portable Vascular Laboratory (PVL) and Vascular Report Generator (VRG) rapidly gained recognition for accuracy and usability.